Sergio Duron

Verified

Member and Manager at Avalon Bioventures ManagementListed on SEC Form ADVLA Jolla, United States

Claim this profile

Cold

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

Enlaza Therapeutics

Board seat (SEC Form D)Source

Since Mar 2021

Company last raised Sep 2025

Portfolio Breakdown

By Sector

Healthcare1 deal · 100%

By Stage

1 tracked deal1 sector · 0 stages

Deal Velocity

Avg Deals / Year

1.0

Avg Deal Size

Unknown

Largest Deal

Enlaza Therapeutics

Unknown

YoY Trend

Steady

Deals Per Year

1 total deal tracked2021–2021

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2021

Less

Current Fund Status

Fund Name

Avalon Bioventures I, LP

Reported Size

$127.5M

Co-Investors

No co-investment data available yet.